Fabry Disease Screening in ESRD Patients in West of France

NCT02719249 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2018-08-28

No results posted yet for this study

Summary

Screening of Fabry disease in end-stage renal disease (ESRD) patients on dialysis or transplant in west of France.

Conditions

  • ESRD

Interventions

OTHER

Dried blood spot test

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02719249 on ClinicalTrials.gov